Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINDE PLCLIN · Entity 2835 | EVP, Chief Operating Officer | March 10, 2026 | March 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINDE PLC
Report date March 10, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 8,150.559 |
Ending reported balance
After 2026-03-10 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-10 · Sale · Disposed 4,114 · Balance 8,150.559 Row 2 · 2026-03-10 · Exercise / conversion · Acquired 7,045 · Balance 15,195.559 Row 3 · 2026-03-10 · Tax withholding · Disposed 4,639 · Balance 10,556.559 F1: Ordinary shares withheld to cover exercise price and tax withholdings. Row 4 · 2026-03-10 · Sale · Disposed 2,406 · Balance 8,150.559 |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 0 |
Reported balance
After 2026-03-10 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-03-10 · Exercise / conversion · Disposed 7,045 · Balance 0 F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09 | Direct | 23,290 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 23,290 F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07 | Direct | 10,889 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 10,889 F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07 | Direct | 9,610 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 9,610 F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07 | Direct | 10,540 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 10,540 F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08 | Direct | 19,070 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 19,070 F10: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,857 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 2,857 F2: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,551 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 1,551 F2: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,470 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,470 F2: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 391.203 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 391.203 F2: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F12: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares withheld to cover exercise price and tax withholdings.
F2: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F10: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F12: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2022 Filed Mar 23, 2022 14:22 UTC | LINDE PLC LIN · Entity 2835 | Tax withholdingOrdinary Shares | 1,005 | $311.66 | $313,218.30 |
DisclosureSEC source: 0001062993-22-008400 · form4.xml · nonDerivative · entry 2 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,541 F2 · shares: Shares of common stock withheld from the payout to cover tax withholdings. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 14:22 UTC | LINDE PLC LIN · Entity 2835 | Exercise / conversionOrdinary Shares | 2,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-008400 · form4.xml · nonDerivative · entry 1 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on March 20, 2019 (the "PSU"). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 15:24 UTC | LINDE PLC LIN · Entity 2835 | GrantDeferred Stock Units · Derivative | 51.66 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007144 · form4.xml · derivative · entry 12 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183.526 Underlying: Ordinary Shares · 183.526 shares Expires not disclosed F11 · derivative.exercise_price: Conversion to Linde plc Ordinary Shares is on a one-to-one basis. F12 · derivative.exercise_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. F12 · derivative.expiration_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 15:24 UTC | LINDE PLC LIN · Entity 2835 | GrantStock Options (right to buy) · Derivative | 12,395 | $0.00 Strike: $270.99 | $0.00 |
DisclosureSEC source: 0001062993-22-007144 · form4.xml · derivative · entry 6 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,395 Underlying: Ordinary Shares · 12,395 shares Expires 2032-03-07 F5 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 15:24 UTC | LINDE PLC LIN · Entity 2835 | GrantRestricted Stock Units · Derivative | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007144 · form4.xml · derivative · entry 2 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 Underlying: Ordinary Shares · 1,430 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 15:23 UTC | LINDE PLC LIN · Entity 2835 | GrantStock Options (right to buy) · Derivative | 19,070 | $0.00 Strike: $253.68 | $0.00 |
DisclosureSEC source: 0001062993-21-002561 · form4.xml · derivative · entry 5 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,070 Underlying: Ordinary Shares · 19,070 shares Expires 2031-03-08 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 15:23 UTC | LINDE PLC LIN · Entity 2835 | GrantRestricted Stock Units · Derivative | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002561 · form4.xml · derivative · entry 2 Durbin Sean · CIK 0001850358 · Executive VP, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810 Underlying: Ordinary Shares · 1,810 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.